Skip to search formSkip to main contentSkip to account menu

J 107088

Known as: J-107088, J107088 
National Institutes of Health

Related topics

Related topics

2 relations
PHA-782615

Broader (1)

edotecarin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
PurposeTo assess the maximum tolerated dose, safety, and pharmacokinetic (PK) profile of escalating doses of the novel… 
2005
2005
Pharmacokinetics (PK) of edotecarin (J-107088), a topoisomerase I inhibitor, in patients with metastatic breast cancer (mBC) or glioblastoma multiforme (GBM)
2073 Background: Edotecarin is an indolocarbazole topoisomerase I inhibitor currently under clinical development for cancer… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)